FDA Inspection 1251888 — Provimi North America, Inc.

Provimi North America, Inc. — FEI 1910466

The FDA completed an inspection of Provimi North America, Inc. on November 25, 2024 in Lewisburg, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 25, 2024
Fiscal Year
2025
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Lewisburg, OH (United States)